IQE is trading 6.1% up now at £40.46 as it rebounds from a sharp selloff triggered by a deeply discounted £81m equity and convertible loan note fundraising.
- The fundraising was priced at 19.8 pence per share, which initially sparked significant dilution and pricing concerns among shareholders.
- Today’s move reflects a partial recovery as investors reassess the company's strategic review outcome and MACOM’s strategic investment support.
- The stock is regaining ground after the market processed the impact of the capital injection on the company's long-term balance sheet.